Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $3.6M (54,575 shares) of Corcept Therapeutics Inc on May 27, 2026. Filing
- Last sale before this period: Oct 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Corcept Therapeutics Inc (CORT) | President, Corcept Endocrinology The | Feb 9, 2018 | Oct 5, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 2, 2026, Corcept Therapeutics Inc: sold 24,587 shares for $2.9M, under a disclosed plan; 24,587 shares acquired by exercising options. 1 filing: 1
- Oct 1, 2026, Corcept Therapeutics Inc: sold 413 shares for $48K, under a disclosed plan; 413 shares acquired by exercising options. 1 filing: 1
- Sep 2, 2026, Corcept Therapeutics Inc: 117 shares withheld by the company for taxes. 1 filing: 1
- Sep 1, 2026, Corcept Therapeutics Inc: sold 25,000 shares for $2.9M, under a disclosed plan; 25,000 shares acquired by exercising options; 300 shares awarded. 1 filing: 1
- Aug 25, 2026, Corcept Therapeutics Inc: sold 30,955 shares for $3.9M, under a disclosed plan; 30,955 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.